Close Menu

NEW YORK (GenomeWeb) – Immunotherapy and companion diagnostic developer Treos Bio said today it has completed an $8 million private investment round.

The new funding will be used to support an early-stage clinical trial of PolyPEPI, a precision immunotherapy vaccine for colorectal cancer. The company expects to begin the trial this year. It plans to use its companion diagnostics to identify patients that could be likely responders to the vaccine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Three US lawmakers call on the Trump Administration to end its program to collect DNA from detained migrants, the Hill reports.

Researchers in the US have developed a promising candidate vaccine against African swine fever, according to Bloomberg News.

Soccer players who head the ball a lot and who have a certain APOE allele may be more likely to have memory problems, according to HealthDay.

In Cell this week: a quantitative proteomic atlas based on the Cancer Cell Line Encyclopedia, gene regulation and differentiation in Toxoplasma gondii, and more.